Potent anticancer activity via dual compound activation
US9592229B2 · kind B2 · utility
8Cited by
8References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 4, 2013 |
| Grant date | Mar 14, 2017 |
| Priority date | — |
| Expiry date | Aug 15, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4858
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods the use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.